Find the latest Tempest Therapeutics, Inc. (TPST) stock quote, history, news and other vital information to help you with your stock trading and investing.

5 天之前 · Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in...

2025年3月14日 · Get a real-time Tempest Therapeutics, Inc. (TPST) stock price with an overview of financials, statistics, forecasts, charts and more.

Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients.

Get the latest Tempest Therapeutics Inc (TPST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

3 天之前 · Get the latest Tempest Therapeutics, Inc TPST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

4 天之前 · According to the 3 analysts' twelve-month price targets for Tempest Therapeutics, the average price target is $26.00. The highest price target for TPST is $47.00, while the lowest price target for TPST is $5.00. The average price target represents a forecasted upside of 2,963.87% from the current price of $0.85.

Discover real-time Tempest Therapeutics, Inc. Common Stock (TPST) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq...

据了解，tpst-1120是一种口服、选择性pparα小分子拮抗剂。 今年4月公布的全球随机1b/2期临床试验的数据显示，tpst-1120在无法切除或转移性肝细胞癌（hcc）患者的一线治疗中，在客观缓解率（orr）上...查看全文. 讨论. 中国图腾09 2024-06-19 08:36

3 天之前 · The latest Tempest Therapeutics stock prices, stock quotes, news, and TPST history to help you invest and trade smarter.